Marson AG,Chadwick DW.New drug treatment for epilepsy. Journal of Neurology Neurosurgery and Psychiatry . 2001Marson AG & Chadwick DW (2001) New drug treatments for epilepsy. J Neurol Neurosurg Psychiatry 70: 143-147.Marson AG, Chadwick DW. New drug treatments for epi- lepsy. J Neurol ...
The new treatment, named the Mental Health Intervention for Children with Epilepsy (MICE), is based on the treatments that the National Institute for Health and Care Excellence (NICE) recommends for the treatment of common mental health difficulties, likecognitive behavioral therapyfor anxiety and dep...
New treatments for epilepsy are sorely needed because current medications don't work for many people with the disease. To find new leads, researchers have now turned to the sea—a source of unique natural products that have been largely untapped for prospective drugs. The scientists report in th...
In the majority of cases, epilepsy develops in three phases: (i) initial brain damaging insult (eg, head trauma, stroke, status epilepticus), resulting in (ii) epileptogenesis, which in turn leads to (iii) recurrent seizures (epilepsy). The current treatment of epilepsy, however, focuses ex...
New GABA-targeting therapies for the treatment of seizures and epilepsy: II. Treatments in clinical development. CNS Drugs 37, 781–795 (2023). Article CAS PubMed PubMed Central Google Scholar Cerne, R. et al. GABAkines — advances in the discovery, development, and commercialization of ...
It is licensed for use as adjunctive treatment of partial-onset seizuresi with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.2 Here we discuss the place of perampanel in the treatment of epilepsy.BMJ...
Animal Research Suggests New Treatment Target For Epilepsy - NewsVirtual Medical Centre Com
Wood H. Epilepsy:new insights into the treatment and Consequences of poststroke epilepsy [ J ] . Nat Rev Neurol, 2015, 11 ( 8 ) : 425.Epilepsy:New insights into the treatment and consequences of poststroke epilepsy. Wood H. Nat Rev Neurol . 2015...
(600 mg/d dose) of patients reported weight gain but this, and adverse events generally, resulted in few discontinuations of the treatment.6,7 In individuals where weight gain may be a concern, physicians should be aware of this possibil- ity so they can manage it appropriately.Pregabalin ...
The lives of most people with epilepsy continue to be adversely affected by gaps in knowledge, diagnosis, treatment, advocacy, education, legislation, and research. Concerted actions to address these challenges are urgently needed. 展开 DOI: 10.1016/S0140-6736(14)60456-6 被引量: 312 ...